Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8694548rdf:typepubmed:Citationlld:pubmed
pubmed-article:8694548lifeskim:mentionsumls-concept:C0370003lld:lifeskim
pubmed-article:8694548lifeskim:mentionsumls-concept:C0348026lld:lifeskim
pubmed-article:8694548lifeskim:mentionsumls-concept:C0242349lld:lifeskim
pubmed-article:8694548lifeskim:mentionsumls-concept:C0220901lld:lifeskim
pubmed-article:8694548lifeskim:mentionsumls-concept:C0336791lld:lifeskim
pubmed-article:8694548pubmed:issue4Blld:pubmed
pubmed-article:8694548pubmed:dateCreated1996-8-29lld:pubmed
pubmed-article:8694548pubmed:abstractTextIn the last two decades, immunocytochemistry has been increasingly used in diagnostic cytopathology and is now part of the routine work in a cytopathological laboratory. Immunostaining successfully complements morphological studies for the identification and classification of tumours, when performed with well-defined monoclonal antibodies (MoAbs). This article will briefly review the MoAbs most frequently utilized for diagnostic purposes and the field in which they may be applied. MoAbs against biological markers for malignant transformation and tumour progression, are now available and the feasibility of their application to clinical cytopathology will be discussed.lld:pubmed
pubmed-article:8694548pubmed:languageenglld:pubmed
pubmed-article:8694548pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8694548pubmed:citationSubsetIMlld:pubmed
pubmed-article:8694548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8694548pubmed:statusMEDLINElld:pubmed
pubmed-article:8694548pubmed:issn0250-7005lld:pubmed
pubmed-article:8694548pubmed:authorpubmed-author:VecchioneAAlld:pubmed
pubmed-article:8694548pubmed:authorpubmed-author:GiovagnoliM...lld:pubmed
pubmed-article:8694548pubmed:issnTypePrintlld:pubmed
pubmed-article:8694548pubmed:volume16lld:pubmed
pubmed-article:8694548pubmed:ownerNLMlld:pubmed
pubmed-article:8694548pubmed:authorsCompleteYlld:pubmed
pubmed-article:8694548pubmed:pagination2225-32lld:pubmed
pubmed-article:8694548pubmed:dateRevised2005-11-16lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:meshHeadingpubmed-meshheading:8694548-...lld:pubmed
pubmed-article:8694548pubmed:articleTitleImmunocytochemistry of cytological specimens as a diagnostic and prognostic tool.lld:pubmed
pubmed-article:8694548pubmed:affiliationDipartimento di Medicina Sperimentale e Patologia, Cattedra di Citopatologia I, Universita' degli Studi di Roma, La Sapienza, Italy.lld:pubmed
pubmed-article:8694548pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8694548pubmed:publicationTypeReviewlld:pubmed